Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AI In Clinical Trials – Big Pharma Execs Outline Journey, Road Ahead

Oct 24 2024

• By Anju Ghangurde

Advances in leveraging AI in clinical trials

Related Content

Sanofi Exec On Go-To-Market Models, MLR Reviews, Ambidextrous Leadership

Oct 21 2024

GenAI Reality In Pharma Amid Hype, Advances In LLMs For Therapeutics

Aug 27 2024

Astellas Exec On Tech Tools For Better Go-No-Go Decisions, Gen AI

Dec 06 2023

Life Sciences Scaling Adoption Of New Metaverse, AI Tools

Oct 02 2023

ChatGPT Unleashed: Generative AI Use Cases Taking Off In Pharma

Jun 06 2023

GSK CTO, Boehringer Exec On The Metaverse And Pharma’s Foot In The Door

Mar 09 2023

Boehringer Ingelheim’s Formula For Scaling Transformation, Digitization

Sep 27 2022

Indegene CTO On Pharma And Blockchain’s Promise Of Better Accountability, Trust

Sep 09 2022

BMS CDTO Meyers On Gen AI Use Cases, Long-Range Planning Models

Mar 08 2024

US FDA Opinions Vary On AI’s Black Box Issues. Will Uncertainty Follow?

Oct 16 2024

AI And The ‘Black Box’ Problem: US FDA Is More Comfortable Than Some May Think

Sep 03 2024

Bayer’s Koenen: Decentralized Trials For Pivotal Studies Not 'Black Or White Scenario'

Mar 31 2022

Related Companies

Novartis AG

Johnson & Johnson

Bayer AG

GSK plc

More from Scrip

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window